Given the interplay of pyruvate and glutamine to sustain the TCA cycle, we reasoned that these two arms of anaplerosis are redundant and together present a targetable metabolic liability in ENO1-deleted glioma cells. The gene discussed is ENO1; the disease is central nervous system cancer.